哌嗪-2-甲酰胺 | 84501-64-4

• 物质功能分类: 医药中间体 - 哌嗪类化合物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 哌嗪-2-甲酰胺
• 英文名称: piperazine-2-carboxamide
• 英文别名: piperazine-2-carboxylic acid amide；rac-piperazine-2-carboxamide；(R,S)-piperazine-2-carboxamide；2-aminocarbonylpiperazine；Pyrazinamide
• CAS: 84501-64-4
• 化学式: C₅H₁₁N₃O
• mdl: MFCD01632533
• 分子量: 129.162
• InChiKey: BRYCUMKDWMEGMK-UHFFFAOYSA-N

物化性质

• 熔点：
  144-145 °C(Solv: ethanol (64-17-5))
• 沸点：
  364.2±37.0 °C(Predicted)
• 密度：
  1.104±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.9
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  67.2
• 氢给体数：
  3
• 氢受体数：
  3

安全信息

• 海关编码：
  2933599090
• 储存条件：
  存储条件：2-8℃，请密封并保持干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Piperazine-2-carboxamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Piperazine-2-carboxamide
CAS number: 84501-64-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H11N3O
Molecular weight: 129.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  哌嗪-2-甲酰胺 在 Novozyme 、 盐酸 作用下， 以 水 为溶剂， 20.0~45.0 ℃ 、12.0 MPa 条件下， 反应 22.75h， 以40%的产率得到(S)-piperazine-2-carboxylic acid dihydrochloride
  参考文献：
  名称：

  [EN] PROCESS FOR THE PREPARATION OF A CHIRAL PIPERAZINE-2-CARBOXYLIC ACID
  [FR] PROCÉDÉ DE PRÉPARATION D'UN ACIDE PIPÉRAZINE-2-CARBOXYLIQUE CHIRAL

  摘要：

  本发明涉及一种制备手性哌嗪-2-羧酸或其盐的新工艺，其化学式为（I）。化学式（I）的手性哌嗪-2-羧酸衍生物是制备融合杂环二氢嘧啶的关键中间体，该化合物对治疗和预防乙型肝炎病毒感染非常有用。

  公开号：

  WO2021219523A1
• 作为产物：
  描述：

  吡嗪酰胺 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 、 水 为溶剂， 以95%的产率得到哌嗪-2-甲酰胺
  参考文献：
  名称：

  Integration of enabling methods for the automated flow preparation of piperazine-2-carboxamide

  摘要：

  在这里，我们描述了一种新的开源软件包和树莓派^®计算机的使用，用于同时控制多个流动化学设备，并将其应用于机器辅助的多步流动制备吡嗪-2-羧酰胺 - Rifater^®的组成部分，用于治疗结核病 - 以及其还原衍生物哌嗪-2-羧酰胺。

  DOI：

  10.3762/bjoc.10.56

文献信息

• [EN] INHIBITORS OF KRAS G12C<br/>[FR] INHIBITEURS DE K-RAS G12C
  申请人：ARAXES PHARMA LLC

  公开号：WO2015054572A1

  公开（公告）日：2015-04-16

  Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, tautomer, prodrug or stereoisomer thereof, wherein R1, R2a, R3a, R3b, R4a, R4b, G1, G2, L1, L2, m1, m2, A, B, W, X, Y, Z and E are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of G12C mutant KRAS protein for treatment of disorders, such as cancer, are also provided.

  提供了作为G12C突变KRAS蛋白抑制剂活性的化合物。这些化合物具有以下结构（I）：或其药用可接受的盐、互变异构体、前药或立体异构体，其中R1、R2a、R3a、R3b、R4a、R4b、G1、G2、L1、L2、m1、m2、A、B、W、X、Y、Z和E如本文所定义。还提供了与制备和使用这些化合物相关的方法，包括含有这些化合物的药物组合物以及调节G12C突变KRAS蛋白活性以治疗癌症等疾病的方法。
• [EN] SUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND USES THEREOF<br/>[FR] PYRROLOTRIAZINES DE BENZOTHIÉNYLE SUBSTITUÉS ET LEURS UTILISATIONS
  申请人：BAYER IP GMBH

  公开号：WO2013124316A1

  公开（公告）日：2013-08-29

  This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.

  这项发明涉及具有蛋白酪氨酸激酶抑制活性的新型取代5-(1-苯并噻吩-2-基)吡咯并[2,1-f][1,2,4]三唑-4-胺衍生物，涉及制备这类化合物的方法，含有这类化合物的药物组合物，以及利用这类化合物或组合物治疗增殖性疾病，特别是癌症和肿瘤疾病的用途。
• [EN] COMBINATION THERAPIES FOR TREATMENT OF CANCER<br/>[FR] THÉRAPIES COMBINATOIRES POUR LE TRAITEMENT DU CANCER
  申请人：ARAXES PHARMA LLC

  公开号：WO2016044772A1

  公开（公告）日：2016-03-24

  Combination therapies for treatment of cancers associated with mutations in the KRAS gene are provided. Compositions comprising therapeutic agents for treatment of cancers associated with mutations in the KRAS gene are also provided.

  提供用于治疗与KRAS基因突变相关的癌症的联合疗法。还提供了包含治疗剂的组合物，用于治疗与KRAS基因突变相关的癌症。
• N-aryl-piperazinealkanamides useful for improving sleep
  申请人：Janssen Pharmaceutica N.V.

  公开号：US04880808A1

  公开（公告）日：1989-11-14

  A method of improving sleep in warm-blooded animals suffering from sleep disorders, which method comprises the administration of particular N-aryl-piperazinealkanamide derivatives and compositions containing the same. Novel N-aryl-piperazinealkanamide derivatives.

  一种改善患有睡眠障碍的温血动物睡眠的方法，该方法包括给予特定的N-芳基哌嗪烷酰胺衍生物和含有相同物质的组合物。新颖的N-芳基哌嗪烷酰胺衍生物。
• N-aryl-piperazinealkanamides useful for protecting hearts from
  申请人：Janssen Pharmaceutica N.V.

  公开号：US04766125A1

  公开（公告）日：1988-08-23

  Novel N-aryl-piperazinealkanamides, having particular substituents attached to one of the carbon atoms of the piperazine ring, which compounds are useful to protect hearts from myocardial injury caused by ischaemia, anoxia or hypoxia.

  新型N-芳基哌嗪烷酰胺，其中特定取代基连接到哌嗪环的一个碳原子上，这些化合物对于保护心脏免受缺血、缺氧或低氧引起的心肌损伤是有用的。